Previous Close | 72.50 |
Open | 72.00 |
Bid | 0.00 x 11000 |
Ask | 74.50 x 8000 |
Day's Range | 72.00 - 72.00 |
52 Week Range | 35.00 - 77.00 |
Volume | |
Avg. Volume | 38 |
Market Cap | 1.175B |
Beta (5Y Monthly) | 1.19 |
PE Ratio (TTM) | 107.46 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 2.00 (2.76%) |
Ex-Dividend Date | May 28, 2024 |
1y Target Est | N/A |
Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland--(Newsfile Corp. - April 29, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) today announced that the company has been granted extension until 31 May 2024 to publish its 2023 annual report and to file such report with SIX Exchange Regulation AG. ...
Ad hoc announcement pursuant to Art. 53 LR Giovanni Di Napoli appointed as new CEO effective from 24 May 2024. Current CEO Alessandro Della Chà to be appointed ...
Dublin, Ireland--(Newsfile Corp. - April 12, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announces that Medtronic plc (NYSE: MDT), a global leader in healthcare technology, presented at the Genius Summit 2024 the latest advancements in artificial intelligence (AI) for endoscopic care by unveiling ColonPRO™, the latest generation software for the GI Genius™ intelligent endoscopy system ...